Mast cell tumor historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Mast cell tumor}} | {{Mast cell tumor}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{AEL}} | ||
==Overview== | ==Overview== | ||
Mast cell activation was first described by Dr. Nettleship and Tay in 1869. Dr. Sezary and other french scientists reported the first case of mast cell tumor in 1936. | |||
==Historical Perspective== | ==Historical Perspective== | ||
=== Discovery === | |||
* In 1869, Dr. Nettleship and Tay were the first ever to discuss the mast cell activation and it was in a case of urticaria pigmentosa.<ref name="pmid29048112">{{cite journal| author=Scherber RM, Borate U| title=How we diagnose and treat systemic mastocytosis in adults. | journal=Br J Haematol | year= 2018 | volume= 180 | issue= 1 | pages= 11-23 | pmid=29048112 | doi=10.1111/bjh.14967 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29048112 }}</ref> | |||
* In 1936, Dr. Sézary and other french scientists reported the first case of systemic mastocytosis or mast cell tumor. | |||
* Dr. Sezary describes the systemic mastocytosis as aberrant mast cell proliferation which is characterized by release of immense vasoactive amines.<ref name="pmid290481122">{{cite journal| author=Scherber RM, Borate U| title=How we diagnose and treat systemic mastocytosis in adults. | journal=Br J Haematol | year= 2018 | volume= 180 | issue= 1 | pages= 11-23 | pmid=29048112 | doi=10.1111/bjh.14967 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29048112 }}</ref> | |||
==References== | ==References== | ||
| Line 16: | Line 22: | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Pathology]] | [[Category:Pathology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
Latest revision as of 15:46, 9 May 2019
|
Mast cell tumor Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mast cell tumor historical perspective On the Web |
|
American Roentgen Ray Society Images of Mast cell tumor historical perspective |
|
Risk calculators and risk factors for Mast cell tumor historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Mast cell activation was first described by Dr. Nettleship and Tay in 1869. Dr. Sezary and other french scientists reported the first case of mast cell tumor in 1936.
Historical Perspective
Discovery
- In 1869, Dr. Nettleship and Tay were the first ever to discuss the mast cell activation and it was in a case of urticaria pigmentosa.[1]
- In 1936, Dr. Sézary and other french scientists reported the first case of systemic mastocytosis or mast cell tumor.
- Dr. Sezary describes the systemic mastocytosis as aberrant mast cell proliferation which is characterized by release of immense vasoactive amines.[2]
References
- ↑ Scherber RM, Borate U (2018). "How we diagnose and treat systemic mastocytosis in adults". Br J Haematol. 180 (1): 11–23. doi:10.1111/bjh.14967. PMID 29048112.
- ↑ Scherber RM, Borate U (2018). "How we diagnose and treat systemic mastocytosis in adults". Br J Haematol. 180 (1): 11–23. doi:10.1111/bjh.14967. PMID 29048112.